losartan has been researched along with angiotensin iii in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 40 (64.52) | 18.2507 |
2000's | 15 (24.19) | 29.6817 |
2010's | 7 (11.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, M; Itazaki, K; Mihara, S; Shigeri, Y | 1 |
Abdelrahman, A; Pang, CC | 1 |
Johnson, AK; Kirby, RF; Thunhorst, RL | 1 |
Dunne, JF; Melching, G; Momiyama, M; Ransom, JT; Sharif, NA | 1 |
Barnes, JC; Hawcock, AB; Michel, AD | 1 |
Byrd, EW; Carr, BR; Rainey, WE; Sinnokrot, RA | 1 |
Harris, PJ; Mendelsohn, FA; Nobes, MS; Yamada, H | 1 |
Fregly, MJ; Rowland, NE | 1 |
Carini, DJ; Chiu, AT; Duncia, JV; Johnson, AL; Price, WA; Timmermans, PB; Wexler, RR; Wong, PC | 1 |
Chang, RS; Lotti, VJ | 1 |
Smith, RD | 1 |
Baker, KM; Dostal, DE; Du, J; Motel, TJ; Thekkumkara, TJ; Thomas, WG | 1 |
Baldi, E; Catalioto, RM; Cioni, A; Finetti, G; Maggi, M; Mancina, R; Renzetti, AR; Serio, M | 1 |
Ahima, RS; Kadowitz, PJ; Khosla, MC; Minkes, RK; Osei, SY; Weaver, JP | 1 |
Chan, JY; Chan, SH; Yang, CC | 1 |
Agnati, LF; Fior, DR; Fuxe, K; Hedlund, PB; Narváez, JA; Yang, SN | 1 |
Smith, RD; Timmermans, PB | 1 |
Radhakrishnan, R; Sim, MK | 1 |
Catalioto, RM; Criscuoli, M; Mizrahi, J; Renzetti, AR; Subissi, A | 1 |
André, P; Corriu, C; Michel, M; Schott, C; Stoclet, JC | 1 |
Bihoreau, C; Clauser, E; Conchon, S; Corvol, P; Monnot, C; Sirieix, ME | 1 |
Feng, CJ; Kadowitz, PJ; Nossaman, BD; Wang, J | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
Inada, Y; Kohara, Y; Kubo, K; Naka, T; Nishikawa, K; Noda, M; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 1 |
Cervoni, P; Crandall, DL; Feliciano, L; Herzlinger, HE; Saunders, BD; Zolotor, RC | 1 |
Bellan, JA; Kadowitz, PJ; Minkes, RK; Osei, SY | 1 |
Baubonis, W; Benfield, P; Chiu, AT; Dunscomb, JH; McCall, DE; Sauer, B | 1 |
Ball, AE; Felgenhauer, GP; Hall, KL; Hanesworth, JM; Harding, JW; Hosick, HL | 1 |
Perrone, MH; Scheuer, DA | 1 |
Cazes, M; Cloarec, A; Provost, D; Versigny, A | 1 |
Coviello, A; Peral de Bruno, M | 1 |
Forster, C; le Tran, Y | 2 |
Eijsman, L; Feenstra, M; Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
García-Sáinz, JA; González-Espinosa, C; Martínez-Alfaro, M; Romero-Avila, MT | 1 |
Dampney, RA; Hirooka, Y; Potts, PD | 1 |
Champion, HC; Czapla, MA; Kadowitz, PJ | 1 |
Breitbart, H; Gur, Y; Lax, Y; Rubinstein, S; Zamir, N | 1 |
Corvol, P; Gasc, JM; Hus-Citharel, A; Llorens-Cortes, C; Marchetti, J; Roques, B; Zini, S | 1 |
Kasahara, T; Kawano, H; Kimura, S; Kitamura, H; Kunieda, Y; Masuda, H; Nakagawa, K; Nakagawa, M; Nakahara, Y; Nishimura, H; Sawada, S; Sugano, T; Tsuji, H; Yano, S; Yoshizumi, M | 1 |
Dixon, B; Rowe, BP | 1 |
Corvol, P; David, C; Fournie-Zaluski, MC; Iturrioz, X; Llorens-Cortes, C; Reaux, A; Roques, BP; Vazeux, G | 1 |
Bianciotti, L; Fernandez, B; Kadarian, C; Rodano, V; Rodriguez-Campos, M; Vatta, M | 1 |
Chan, JY; Chan, SH; Lin, K | 1 |
Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
Bica, RB; Caruso-Neves, C; Correa, JS; Lara, LS; Lopes, AG; Marques-Fernandes, MF; Sena, SL | 1 |
Corvol, P; Hus-Citharel, A; Llorens-Cortes, C; Marchetti, J | 1 |
Harding, JW; Llorens-Cortes, C; Roques, BP; Speth, RC; Tamura-Myers, E; Wilson, WL; Wright, JW | 1 |
Bagi, EE; Fekete, E; Lénárd, L | 1 |
Lachowicz-Ochedalska, A; Rebas, E | 1 |
Buczko, W; Chabielska, E; Mogielnicki, A; Pawlak, R; Szemraj, J | 1 |
Butler, DG | 1 |
Georgiev, V; Tchekalarova, J | 1 |
Campbell, WB; Cui, L; Gauthier, KM; Nithipatikom, K; Zhang, DX | 1 |
Guethe, LM; Juliano, MA; Martins, AR; Pelegrini-da-Silva, A; Prado, WA; Rosa, E | 1 |
Tang, CS; Wang, HX; Wang, W; Zeng, XJ; Zhang, LK; Zhang, QF | 1 |
Clark, MA; Nguyen, C; Tran, H | 1 |
Domińska, K; Lachowicz-Ochędalska, A; Ochędalski, T; Piastowska-Ciesielska, AW | 1 |
Campbell, WB; Gomez-Sanchez, CE; Gomez-Sanchez, EP; Kopf, PG; Luis Lam, M; Oki, K; Yamazaki, T | 1 |
Cha, SA; Gao, S; Kang, KP; Kim, SH; Oh, YB; Park, BM | 1 |
Clark, MA; Haspula, D; Kandalam, U; Sarmiento, N | 1 |
Ahmad, M; Leenen, FHH; Llorens-Cortes, C; Marc, Y | 1 |
2 review(s) available for losartan and angiotensin iii
Article | Year |
---|---|
Human angiotensin receptor subtypes.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; DNA, Complementary; Gene Library; Humans; Imidazoles; Losartan; Oligopeptides; Pyridines; Receptors, Angiotensin; Tetrazoles | 1994 |
Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arteries; Binding Sites; Blood Pressure; Brain; CD13 Antigens; Dose-Response Relationship, Drug; Glutamyl Aminopeptidase; Hypertension; Hypothalamus; Losartan; Mice; Models, Chemical; Mutagenesis, Site-Directed; Peptides; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Thermolysin; Vasopressins | 2000 |
60 other study(ies) available for losartan and angiotensin iii
Article | Year |
---|---|
Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Biphenyl Compounds; Calcium; Cells, Cultured; Endopeptidases; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Losartan; Membranes; Muscle, Smooth, Vascular; Pyridines; Swine; Tetrazoles | 1992 |
Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles | 1992 |
Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cerebral Ventricles; Drinking Behavior; Imidazoles; Injections, Intraventricular; Losartan; Male; Rats; Rats, Inbred Strains; Reference Values; Tetrazoles; Time Factors | 1992 |
AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Calcium; Imidazoles; Intracellular Membranes; Losartan; Neuroblastoma; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured | 1992 |
Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.
Topics: Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Bacitracin; Biphenyl Compounds; Dithiothreitol; Ganglia, Sympathetic; Imidazoles; In Vitro Techniques; Losartan; Male; Neuromuscular Depolarizing Agents; Oligopeptides; Peptides; Protease Inhibitors; Rats; Tetrazoles | 1992 |
Angiotensin-II activation of cAMP and corticosterone production in bovine adrenocortical cells: effects of nonpeptide angiotensin-II antagonists.
Topics: Adrenal Cortex; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cattle; Corticosterone; Cyclic AMP; Imidazoles; Losartan; Pyridines; Saralasin; Tetrazoles | 1991 |
Effects of angiotensin on renal cortical and papillary blood flows measured by laser-Doppler flowmetry.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta; Aprotinin; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Constriction; Dose-Response Relationship, Drug; Imidazoles; Indomethacin; Kidney Cortex; Kidney Medulla; Lasers; Losartan; Male; Rats; Rats, Inbred WKY; Tetrazoles | 1991 |
Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cerebral Ventricles; Drinking Behavior; Imidazoles; Injections, Intraventricular; Injections, Subcutaneous; Losartan; Male; Mice; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Reference Values; Tetrazoles; Time Factors | 1991 |
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Topics: Administration, Oral; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Losartan; Male; Rabbits; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1990 |
Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Azoles; Binding, Competitive; Biphenyl Compounds; Cell Membrane; Dithiothreitol; Imidazoles; In Vitro Techniques; Ligands; Losartan; Pyridines; Rats; Receptors, Angiotensin; Saralasin | 1990 |
Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Cell Line; Epithelium; Imidazoles; Intestinal Mucosa; Intestine, Small; Losartan; Oligopeptides; Peptide Fragments; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles | 1995 |
Stable expression of a functional rat angiotensin II (AT1A) receptor in CHO-K1 cells: rapid desensitization by angiotensin II.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Base Sequence; Calcium; Cell Membrane; CHO Cells; Concanavalin A; Cricetinae; Gene Expression; Guanosine Triphosphate; Imidazoles; Losartan; Membrane Potentials; Molecular Sequence Data; Pyridines; Rats; Receptors, Angiotensin; Tetradecanoylphorbol Acetate; Tetrazoles; Transfection; Verapamil | 1995 |
Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Binding, Competitive; Biphenyl Compounds; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Imidazoles; Kinetics; Losartan; Neuroblastoma; Oligopeptides; Pyridines; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1995 |
Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Arginine; Biphenyl Compounds; Cats; Hindlimb; Imidazoles; Losartan; Meclofenamic Acid; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Perfusion; Tetrazoles; Vascular Resistance; Vasoconstriction | 1993 |
Central effect of angiotensin III on caudal hypoglossal neurons in rats.
Topics: Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Brain; Carbachol; Electrophysiology; Hypoglossal Nerve; Imidazoles; Injections, Intraventricular; Losartan; Male; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Saline Solution, Hypertonic; Tetrazoles | 1995 |
Evidence for an antagonistic angiotensin II/alpha 2-adrenoceptor interaction in the nucleus tractus solitarii.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Imidazoles; Losartan; Male; Microinjections; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Software; Solitary Nucleus; Specific Pathogen-Free Organisms; Tetrazoles | 1994 |
Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1994 |
Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Epoprostenol; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle, Smooth; Pyridines; Rabbits; Receptors, Angiotensin; Tetrazoles; Vas Deferens | 1994 |
ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells.
Topics: Actins; Angiotensin I; Angiotensin III; Animals; Aorta, Thoracic; Biphenyl Compounds; Calcium; Cattle; Cell Division; Cells, Cultured; Endothelium, Vascular; Imidazoles; Inositol 1,4,5-Trisphosphate; Kinetics; Losartan; Male; Muscle, Smooth, Vascular; Phenotype; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1994 |
Synthetic cDNA encoding the rat AT1a receptor: a useful tool for structure-function relationship analysis.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Base Sequence; Biphenyl Compounds; CHO Cells; Codon; Cricetinae; DNA, Complementary; Imidazoles; Kinetics; Losartan; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Oligopeptides; Open Reading Frames; Pyridines; Rats; Receptors, Angiotensin; Restriction Mapping; Saralasin; Signal Transduction; Structure-Activity Relationship; Tetrazoles; Transfection | 1994 |
Analysis of angiotensins I, II, and III in pulmonary vascular bed of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Blood Vessels; Captopril; Enalaprilat; Imidazoles; In Vitro Techniques; Losartan; Male; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin III; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hindlimb; Imidazoles; In Vitro Techniques; Losartan; Male; Molecular Sequence Data; Rats; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Tetrazoles | 1993 |
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethy
Topics: Adrenal Cortex; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cattle; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prodrugs; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Substrate Specificity; Tetrazoles | 1993 |
Identification and characterization of angiotensin II receptors in rat epididymal adipocyte membranes.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adipose Tissue; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Biphenyl Compounds; Cell Membrane; Epididymis; Imidazoles; Losartan; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Saralasin; Temperature; Tetrazoles | 1993 |
Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
Topics: Angiotensin II; Angiotensin III; Animals; Biphenyl Compounds; Blood Pressure; Cats; Dose-Response Relationship, Drug; Female; Imidazoles; Losartan; Male; Perfusion; Tetrazoles | 1993 |
Characterization of angiotensin AT1A receptor isoform by its ligand binding signature.
Topics: Adrenal Cortex; Angiotensin I; Angiotensin III; Animals; Base Sequence; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Imidazoles; Losartan; Molecular Sequence Data; Muscle, Smooth, Vascular; Nicotinic Acids; Pyridines; Rats; Receptors, Angiotensin; Recombinant Proteins; Saralasin; Tetrazoles; Transfection | 1993 |
Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Biphenyl Compounds; Cattle; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Imidazoles; Losartan; Molecular Sequence Data; Muscle, Smooth, Vascular; Pyridines; Radioligand Assay; Receptors, Angiotensin; Tetrazoles | 1993 |
Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Losartan; Male; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Saralasin; Tetrazoles | 1993 |
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dogs; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Species Specificity; Tetrazoles; Vasoconstrictor Agents | 1995 |
Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
Topics: Analysis of Variance; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Bufo arenarum; Dose-Response Relationship, Drug; Drug Interactions; Female; Imidazoles; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Osmolar Concentration; Osmosis; Pyridines; Skin; Tetrazoles; Vasoconstrictor Agents | 1996 |
Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Enalapril; Endothelium, Vascular; Imidazoles; Losartan; Male; Pyridines; Rabbits; Receptors, Angiotensin; Tetrazoles | 1996 |
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Topics: Aged; Aged, 80 and over; Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutamyl Aminopeptidase; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Metalloendopeptidases; Methionyl Aminopeptidases; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptides; Protease Inhibitors; Pyridines; Saphenous Vein; Tachyphylaxis; Tetrazoles; Vasoconstrictor Agents | 1997 |
Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Enzyme Activation; Guinea Pigs; Imidazoles; Irbesartan; Liver; Losartan; Male; Polymerase Chain Reaction; Pyridines; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1997 |
Angiotensin-(1-7) and the rat aorta: modulation by the endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1997 |
Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Denervation; Female; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Pressoreceptors; Pyridines; Rabbits; Receptors, Angiotensin; Sympathetic Nervous System | 1997 |
Responses to angiotensin peptides are mediated by AT1 receptors in the rat.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Hindlimb; Imidazoles; Losartan; Male; Norepinephrine; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1998 |
Angiotensin II induces acrosomal exocytosis in bovine spermatozoa.
Topics: Acrosin; Acrosome; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Calcimycin; Cattle; Exocytosis; Female; Humans; Imidazoles; Losartan; Male; Pyridines; Receptors, Angiotensin; Sperm Capacitation; Sperm-Ovum Interactions | 1998 |
Aminopeptidase A activity and angiotensin III effects on [Ca2+]i along the rat nephron.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Calcium; Glutamyl Aminopeptidase; Imidazoles; Immunohistochemistry; In Vitro Techniques; Intracellular Fluid; Losartan; Male; Nephrons; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 1999 |
The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Aorta; Blood Coagulation; Endothelium, Vascular; Fibrinolysis; Gene Expression Regulation; Imidazoles; Lipoproteins; Losartan; Plasminogen Activator Inhibitor 1; Pyridines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thromboplastin; Tissue Plasminogen Activator | 1999 |
Angiotensin III depressor action in the conscious rabbit is blocked by losartan but not PD 123319.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Imidazoles; Losartan; Male; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2000 |
AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.
Topics: Angiotensin III; Angiotensin Receptor Antagonists; Animals; Enzyme Inhibitors; Hypothalamus; Imidazoles; In Vitro Techniques; Inositol Phosphates; Losartan; Male; Neurons; Norepinephrine; Potassium Chloride; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Synaptic Transmission; Type C Phospholipases; Tyrosine 3-Monooxygenase | 2000 |
Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Drug Interactions; Functional Laterality; Heart Rate; Imidazoles; Losartan; Male; Medulla Oblongata; Neurons; Pressoreceptors; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reticular Formation; Time Factors | 2001 |
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents | 2001 |
Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Tubules, Proximal; Losartan; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Saralasin; Sodium-Potassium-Exchanging ATPase; Swine | 2002 |
Potentiation of [Ca2+]i response to angiotensin III by cAMP in cortical thick ascending limb.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Biological Transport; Calcium; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; In Vitro Techniques; Intracellular Membranes; Kidney Cortex; Loop of Henle; Losartan; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2002 |
Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Brain; CD13 Antigens; Dose-Response Relationship, Drug; Glutamyl Aminopeptidase; Injections, Intraventricular; Losartan; Male; Methionine; Rats; Rats, Sprague-Dawley; Stereoisomerism; Sulfonic Acids; Vasoconstrictor Agents | 2003 |
Angiotensin II and III microinjections into the zona incerta influence drinking behavior.
Topics: Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Drug Interactions; Imidazoles; Losartan; Male; Microinjections; Oligopeptides; Pyridines; Rats; Subthalamus; Time Factors | 2003 |
The effect of angiotensin III on protein tyrosine kinase activity in rat pituitary.
Topics: Angiotensin II; Angiotensin III; Animals; CD13 Antigens; Imidazoles; Losartan; Methionine; Peptides; Pituitary Gland; Protein Binding; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2005 |
Angiotensin II enhances thrombosis development in renovascular hypertensive rats.
Topics: alpha-2-Antiplasmin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Animals; Blood Pressure; Carotid Arteries; Fibrin; Heart Rate; Hypertension, Renovascular; Infusions, Intravenous; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Recombinant Proteins; Regional Blood Flow; Tissue Plasminogen Activator; Venous Thrombosis | 2005 |
Pressor responses to alligator Angiotensin I and some analogs in the spectacled caiman (Caiman crocodilus).
Topics: Alligators and Crocodiles; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Epinephrine; Losartan; Male; Norepinephrine | 2006 |
Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Animals; Convulsants; Desipramine; Imidazoles; Injections, Intraperitoneal; Injections, Intraventricular; Losartan; Male; Mice; Mice, Inbred ICR; Norepinephrine; Pentylenetetrazole; Pyridines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Restraint, Physical; Seizures; Stress, Psychological; Sympathetic Nervous System | 2006 |
Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Cortex; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Arteries; Cattle; Endothelium, Vascular; Imidazoles; Losartan; Nitric Oxide; Peptide Fragments; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter.
Topics: Analgesics; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Disease Models, Animal; Drug Interactions; Efferent Pathways; Glutamyl Aminopeptidase; Losartan; Male; Microinjections; Neural Inhibition; Nociceptors; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptides; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Angiotensin | 2009 |
Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro.
Topics: Angiotensin II; Angiotensin III; Animals; Animals, Newborn; Captopril; Cell Proliferation; Cells, Cultured; Collagen; DNA; Fibroblasts; Heart; Losartan; Male; Methionine; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Sulfonic Acids | 2010 |
Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Astrocytes; Brain Stem; Cells, Cultured; Cerebellum; Enzyme Inhibitors; Flavonoids; Imidazoles; Losartan; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley | 2011 |
Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation.
Topics: Angiotensin II; Angiotensin III; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Losartan; Male; Prostatic Neoplasms; Pyridines; Structure-Activity Relationship | 2012 |
Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Cell Line; Cytochrome P-450 CYP11B2; Humans; Hydrocortisone; Losartan; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase | 2013 |
Angiotensin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin III; Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Atria; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Losartan; Male; Myocardial Contraction; Perfusion; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Signal Transduction | 2013 |
Angiotensin III induces signal transducer and activator of transcription 3 and interleukin-6 mRNA levels in cultured rat astrocytes.
Topics: Angiotensin III; Animals; Astrocytes; Cells, Cultured; Cyclic S-Oxides; DNA; Gene Expression Regulation; Imidazoles; Interleukin-6; Losartan; Phosphorylation; Pyridines; Rats, Sprague-Dawley; RNA, Messenger; STAT3 Transcription Factor; Time Factors | 2015 |
Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin III; Animals; Brain; Disease Models, Animal; Disulfides; Enzyme Inhibitors; Fibrosis; Glutamyl Aminopeptidase; Heart Failure; Injections, Subcutaneous; Losartan; Male; Myocardial Infarction; Rats, Wistar; Signal Transduction; Sulfonic Acids; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2019 |